Categories for Händelser

Intervju med Martin Vidaeus, VD

December 5, 2019 3:55 pm Published by jonas

Video presentation (ENG) of clinical status of RP101 by CEO Martin Vidaeus

December 5, 2019 3:54 pm Published by jonas

Presentation under BioStock Live

September 2, 2019 11:04 am Published by jonas

Intervju VD: Uppdatering finansiering och status Fas II-prövningen

June 19, 2019 3:54 pm Published by jonas

Presentation under Stora Aktiedagen Stockholm 2018

November 26, 2018 9:55 pm Published by jonas

Videointervju under Småbolagsdagen 2018

June 13, 2018 9:55 am Published by jonas

Videointervju under Aktiedagen Lund 2018

January 30, 2018 12:00 pm Published by jonas

Videointervju under Småbolagsdagen 2017

June 16, 2017 12:00 pm Published by jonas

Analyst Group presenterar investeringsanalys av Redwood Pharma

June 13, 2017 12:00 pm Published by jonas

Redwood Pharma AB – End of Year Report 2016

February 15, 2017 12:00 pm Published by jonas

Redwood Pharma

We develop ophthalmic drugs that address major medical needs. We focus on early-stage clinical development. Our long-term strategy is to enter into licence agreements with other drug companies who will in turn introduce products for the global market.

Redwood Pharma

Vi utvecklar ögonläkemedel för stora medicinska behov. Tonvikten ligger på tidig klinisk utveckling. Den långsiktiga strategin är att teckna licensavtal med andra läkemedelsbolag, som i sin tur kan introducera produkterna på världsmarknaden.